<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="147452">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01180868</url>
  </required_header>
  <id_info>
    <org_study_id>08-02-049</org_study_id>
    <secondary_id>DE-PS02-08ER08-01</secondary_id>
    <secondary_id>CIRM No. RT1-01126-1</secondary_id>
    <nct_id>NCT01180868</nct_id>
  </id_info>
  <brief_title>The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases</brief_title>
  <official_title>The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jonsson Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jonsson Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the biodistribution of a new agent 1-L-(2
      deoxy-2,-18fluoroarabinofuranosyl) cytosine non-invasively in healthy humans and to evaluate
      whether it can be used to image cancer, autoimmune disease, and inflammation
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">1</enrollment>
  <condition>Autoimmune Diseases</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>patients with cancer</arm_group_label>
    <description>patients with hematological malignancies and solid tumors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with autoimmune dosorders</arm_group_label>
    <description>patients with Rheumatoid arthritis, Crohns's disease, systemic lupus erythematosus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cancer, patients with autoimmune dosorders, and healthy subjects.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  greater than 18 years of age

          -  women of childbearing potential will undergo a pregnancy test free of charge

          -  patients with hematological malignancies, solid tumors or autoimmune disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiaan Schiepers, M.D. Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <lastchanged_date>July 27, 2012</lastchanged_date>
  <firstreceived_date>August 11, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>imaging probe</keyword>
  <keyword>cancer</keyword>
  <keyword>inflammatory tissue</keyword>
  <keyword>inflammatory diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
